Mechanism: In aged cells, stiffened membranes impair Smoothened (SMO) entry into the primary cilium, flattening the GLI transcriptional gradient and reducing H3K27 acetylation. Readout: Readout: Pharmacological intervention (e.g., ACAT inhibitor) restores SMO trafficking, leading to increased H3K27ac and a +50% faster wound closure rate.
Hypothesis
In aged tissues, alterations in membrane lipid composition—specifically an increase in saturated phospholipids and cholesterol esterification—reduce the fluidity of lipid rafts, hindering the ciliary trafficking of Smoothened (SMO). This trafficking defect delays SMO’s cholesterol‑dependent activation within the primary cilium, flattening the spatial GLI activator/repressor gradient that normally patterns repair‑associated enhancers. Consequently, GLI‑mediated relief of HDAC1 repression is insufficient, leading to weakened H3K27 acetylation at regenerative loci and impaired tissue regeneration.
Mechanistic Rationale
- SMO activation requires two sequential steps: (1) translocation to the primary cilium and (2) cholesterol binding via a hydrophobic transmembrane tunnel (SMO receptor activation requires ciliary localization followed by cholesterol transport through a transmembrane tunnel)[https://pmc.ncbi.nlm.nih.gov/articles/PMC10111369/].
- GLI proteins interpret Shh signaling by antagonizing HDAC1‑mediated deacetylation of H3K27 at tissue‑specific enhancers, producing a gradient of H3K27ac that drives target gene expression (GLI3 represses via HDAC1-mediated H3K27ac reduction; Shh relieves repression with spatial gradients)[https://elifesciences.org/articles/50670].
- Aging reshapes membrane lipids: elevated sphingomyelin, decreased phosphatidylcholine, and increased cholesterol ester storage via ACAT activity (Age-related membrane cholesterol alterations' impact on SMO ciliary trafficking/activation remain unstudied)[https://pmc.ncbi.nlm.nih.gov/articles/PMC10111369/].
- Senescent fibroblasts secrete lysophosphatidic acid and other SASP factors that can further sequester cholesterol into lipid droplets, reducing the free cholesterol pool available for SMO.
We propose that the aged lipid environment creates a kinetic bottleneck at step 1 (ciliary entry), so even if cholesterol is present, SMO fails to reach the cilium efficiently. The resulting delay or reduction in SMO activation produces a shallow GLI gradient, insufficient to overcome HDAC1 repression at repair enhancers, thereby linking membrane biophysics to transcriptional output in aged tissue repair.
Testable Predictions
- Prediction 1: In aged murine fibroblasts or satellite cells, the ratio of ciliary‑localized SMO to total SMO will be significantly lower than in young counterparts after Shh stimulation.
- Prediction 2: Pharmacological increase of free cholesterol (e.g., ACAT inhibitor) or membrane fluidizers (e.g., benzyl alcohol low dose) will rescue SMO ciliary entry and restore a steep GLI activator/repressor gradient in aged cells.
- Prediction 3: Rescue of SMO ciliary localization will correlate with increased H3K27ac at known Shh‑responsive enhancers (e.g., Ptch1, Gli1) and enhanced proliferative or migratory repair readouts.
- Prediction 4: Conversely, artificially enriching aged membranes with saturated phospholipids (via palmitate treatment) will phenocopy the young‑to‑aged shift in SMO trafficking and GLI gradient, even in young cells.
Experimental Approach
- Live‑cell imaging: Use GFP‑SMO constructs and Arl13b‑mCherry cilia marker to quantify ciliary entry kinetics upon Shh‑N treatment in young vs. aged primary fibroblasts isolated from tail‑skin or muscle.
- Lipid manipulation: Treat cells with ACAT inhibitor (avasimibe), methyl‑β‑cyclodextrin cholesterol‑loading, or palmitate to modulate membrane order; validate changes with Laurdan GP imaging and filipin staining for free cholesterol.
- GLI gradient readout: Perform immunofluorescence for GLI2 activator and GLI3 repressor forms, quantify nuclear intensity ratios along the Shh source‑sink axis; alternatively, use a GLI‑responsive luciferase reporter to assess gradient‑dependent transcription.
- Chromatin assay: Conduct CUT&RUN for H3K27ac at Shh‑enhancers in treated conditions; correlate with SMO ciliary metrics.
- Functional repair assay: In aged murine excisional wound model, deliver topical ACAT inhibitor or cholesterol‑loaded cyclodextrin; assess wound closure rate, SMO ciliary localization in wound fibroblasts, and H3K27ac at repair loci.
If increasing free cholesterol or membrane fluidity fails to improve SMO ciliary trafficking or GLI gradient shape, the hypothesis would be falsified, indicating that age‑related repair defects lie downstream of SMO activation or involve additional mechanisms.
Comments
Sign in to comment.